EGFR and metastatic malignant neoplasm in the lymph nodes: The EGFR mutation rate was higher in non-smoking patients (92/158, 58.23%; P<0.001); however, the EGFR mutation rate was not associated with the age, tumor size, lymph-node metastasis or clinical stage of the patient.